Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 234-974-5 | CAS number: 12047-11-9
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Two different in vitro studies were performed to evaluate the mutagenicity of barium hexaferrite. In Salmonella and E.coli the substance did not shown mutagenic activity, while some positive results were observed in vitro micronucleus test performed on V79 and CHO cell lines. During the preliminary citotoxicity test (performed in order to evaluate the most suitable concentrations of test substance for both CHO and V79 cells), an unexpected, marked citotoxicity was observed in CHO cells not exposed to the substance but treated with metabolic activator S9. For this reason, CHO cells were tested with the substance only in absence of S9 activation, while V79 cells were exposed to barium hexaferrite both with and without S9. Positive results were observed at the highest concentration levels tested for both CHO and V79 cells; in V79 cells the mutagen activity was observed only in presence of metabolic system. Overall, the results are unclear. The citotoxicity due to S9 in CHO cells and the different results observed in the two cell lines would make desirable a verification by means of an in vivo test, as it is foreseen by the Regulation EC 1907/2006. However, toxicokinetics evidences do not support the adsorption (after oral administration) and the subsequently reaching of the target tissue by the substance, making non reliable the validated in vivo mutagenicity tests. Indeed, B.11 (In Vivo Mammalian Bone Marrow Chromosome Aberration Test) and B.12 (In Vivo Mammalian Erythrocyte Micronucleus Test) sections of the Regulation CE 440/2008 reports that: "If there is evidence that the test substance, or a reactive metabolite, will not reach the target tissue, it is not appropriate to use this test".
In light of above issue, no further test was performed.
Short description of key information:
In vitro studies gave conflicting results. The Ames test was negative in all tested strains without and with metabolic activation, regardless the concentration tested. In vitro micronucleus test in V79 and CHO cells showed some mutagenic activity at the highest dose levels tested. In vivo testing was considered scientifically unjustified. Because the toxicokinetics evidences show that barium hexaferrite is not able to reach target organs.
Endpoint Conclusion:
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
